| Methods for treating short bowel syndrome and/or high output ostomy |
2023-5-02 |
2023-10-19 |
|
| Compositions and methods for inhibiting rho kinase |
2023-2-09 |
2023-8-17 |
|
| Compounds and methods for treating tight junction permeability |
2023-2-08 |
2023-10-26 |
|
| Compositions and methods for treating inflammatory bowel disease |
2022-2-23 |
2022-9-01 |
|
| Larazotide formulations |
2022-2-06 |
2022-4-01 |
|
| Compositions and methods for treating pulmonary fibrosis |
2021-11-15 |
2022-5-27 |
|
| Compositions and methods for treating sjogren's syndrome |
2021-11-03 |
2022-2-17 |
|
| Peptide inhibitors of tight junction permeability |
2021-9-24 |
2022-1-13 |
|
| Compositions and methods for treating disease associated with permeability of … |
2021-6-10 |
2021-9-30 |
|
| Compositions and methods for potentiating immune checkpoint inhibitor therapy |
2021-4-23 |
2021-8-05 |
|
| Larazotide derivatives comprising d-amino acids |
2021-4-15 |
2021-10-21 |
|
| Compositions and methods for potentiating immune checkpoint inhibitor therapy |
2021-2-10 |
2021-6-10 |
|
| Formulations for a tight junction effector |
2021-2-01 |
2021-5-27 |
|
| Larazotide formulations |
2020-8-14 |
2022-3-10 |
|
| Composition and methods for rectal delivery of 4-aapa and 5-asa compounds |
2020-4-13 |
2020-10-15 |
|
| Compositions and methods for treating or preventing hyperglycemia, insulin … |
2019-4-08 |
2021-3-11 |
|
| Compounds and methods for treating tight junction permeability |
2019-2-25 |
2020-12-17 |
|
| Compositions and methods for treating or preventing intestinal paracellular … |
2019-2-25 |
2021-2-04 |
|
| Methods of treating celiac disease with larazotide |
2018-3-27 |
2018-9-27 |
|
| Novel inhibitors of mammalian tight junction opening |
2018-1-02 |
2018-5-17 |
|
| Methods and compositions for the diagnosis of crohn's disease |
2016-8-12 |
2016-12-01 |
|
| Use of tight junction antagonists in the treatment of acute lung injury and … |
2016-8-12 |
2016-12-08 |
|
| Methods of diagnosing and treating asthma |
2016-8-12 |
2016-12-08 |
|
| Use of tight junction antagonists to treat inflammatory bowel disease |
2016-2-03 |
2016-6-02 |
|
| Materials and methods for the treatment of celiac disease |
2016-1-26 |
2016-12-29 |
|
| Transcutaneous delivery of therapeutic agents |
2014-4-02 |
2014-10-02 |
|
| Novel peptides that enhance tight junction permeability |
2013-9-10 |
2014-6-19 |
|
| Larazotide acetate compositions |
2013-3-15 |
2013-10-24 |
|
| Formulations for a Tight Junction Effector |
2012-6-27 |
2014-7-10 |
2014-7-10 |
| Peptide conjugates |
2011-6-24 |
2012-2-02 |
|
| Peptide production and purification process |
2011-4-21 |
2013-11-14 |
2013-11-14 |
| Method of diagnosing celiac disease |
2007-8-07 |
2008-2-14 |
|
| Oral delivery of therapeutic agents using tight junction agonists |
2007-2-09 |
2008-11-26 |
|
| Method of use of antagonists of zonulin to prevent the loss of or to regenerate … |
2006-6-09 |
2008-8-13 |
|